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Abstract: Several studies have explored the antimicrobial properties of manuka honey (MkH).
However, the data available regarding antibacterial action mechanisms are scarcer. The aim of
this study was to scrutinize and characterize primary effects of manuka honey (MkH) upon the
physiological status of Staphylococcus aureus and Escherichia coli (as Gram-positive and Gram-negative
bacteria models, respectively), using flow cytometry (FC) to reveal its antibacterial action mechanisms.
Effects of MkH on membrane potential, membrane integrity and metabolic activity were assessed
using different fluorochromes in a 180 min time course assay. Time-kill experiments were carried out
under the same conditions. Additionally, MkH effect on eﬄux pumps was also studied in an E. coli
strain with an over-expression of several eﬄux pumps. Exposure of bacteria to MkH resulted in
physiological changes related to membrane potential and membrane integrity; these effects displayed
slight differences among bacteria. MkH induced a remarkable metabolic disruption as primary
physiological effect upon S. aureus and was able to block eﬄux pump activity in a dose-dependent
fashion in the E. coli strain.
Keywords: manuka honey; flow cytometry; antibacterial effects; bacteria models; metabolic activity;
eﬄux pump
1. Introduction
The emergence of multi-drug-resistant pathogens is one of the most pressing concerns of public
health and food industry worldwide; the situation is especially disturbing in the case of bacteria [1,2].
The excessive and inadequate use of antibiotics clearly contributes to the development of resistance,
usually through genetic changes [3]. Community and hospital settings represent the principal ecological
niches of resistance emergence in human health. Moreover, the intensification of food animal production,
led to an extensive antibiotics administration, not only as therapeutics, but also as prophylactics or
growth promoters increasing the emergence and spread of drug-resistance [2,4]. As a consequence,
some common infections have become extremely difficult, or even impossible, to treat [1,5]. Indeed,
the World Health Organization predicts that infections involving antibiotic resistant pathogens will
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pose major patient care management issues, which inevitably increases in the hospital stays, patient
morbidity and mortality [6]
Staphylococcus aureus and Escherichia coli are commonly involved in infections of both community
and healthcare settings and are amongst the leading causative agents of food-borne infections
worldwide. In addition, according to the last surveillance of antimicrobial resistance in Europe,
these bacterial species currently present resistance to multiple antimicrobial groups [3]. The above
scenario stresses the need to uncover new therapeutic or co-adjuvant options, ideally not prone to
resistance development. In this context, several studies have explored the antibacterial properties and
mechanisms of action of manuka honey (MkH) [7–9] which is produced from Leptospermum species,
native to New Zealand and Australia. The antimicrobial activity of this variety of honey is connected
with common factors such as, osmotic pressure (as result of the high concentration of sugars), acidity or
oxidative stress. Furthermore, MkH exhibits non-peroxide antibacterial activity related to the presence,
in high concentrations, of compounds such as methylgloxal or leptosin [10,11].
Despite the numerous studies on the antibacterial properties of honey it use as an antibacterial
agent remains underestimated, partly due to the lack of comprehensive scientific evidence supporting its
use [9,12,13]. Therefore, more investigations elucidating the role that MkH could play as an antimicrobial
agent are necessary.
Flow cytometry (FC) has been widely applied to study the antimicrobial susceptibility and
characterization of resistance mechanisms of several microorganisms [14–18]. Unlike other techniques,
FC goes beyond classical methodologies in which bacterial viability is generally equated with the ability
to grow and subsequently generate a colony of cells. However, for some bacterial cells the viability is
not so strictly related to grow capacity. Indeed, although bacteria may lack the ability to reproduce and
grow under certain conditions, cells may still possess many of the properties of the fully functional
viable cells [19,20]. In addition, using specific fluorochromes, FC allows to evaluate the physiological
states of bacteria, which confirm the phenotypic changes suggested by other methodologies, such as
genomics or proteomics [19].
The aim of this study was to evaluate the physiological changes induced by MkH upon Escherichia
coli and Staphylococcus aureus in a time course assay, using a FC protocol which was adapted for the
purpose. This research is essential to understand honey’s targets when acting as an antimicrobial and
to further explore the therapeutic potential of this natural product.
2. Results
2.1. Manuka Honey-Induced Alterations in S. aureus CECT 86 and E. coli CECT 515
2.1.1. Effects of MkH on Cell Viability
Figure 1 represents reference strains viability (S. aureus CECT 86 (a) and E. coli CECT 515 (b))
following application of the two MkH concentrations under test in comparison to the non-treated cells.
A significant growth reduction was registered soon after 30 min of incubation with both
concentrations (p < 0.05). CFU counts of the treated S. aureus decreased progressively throughout time
up to 120 min of treatment, time in which CFU counts stabilized (Figure 1a). On the other hand, E. coli
viability decreased progressively along the time up to the end of the treatment (p < 0.05) (Figure 1b).
Significant differences between honey-treated and non-treated cells, and between both treatment
concentrations tested on each microorganism were observed at all time points sampled (p < 0.05).
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Figure 1. Effect of MkH on S. aureus CECT 86 (a) and E. coli CECT 515 (b) cell viability assessed by colony forming units (CFU) counting (expressed in Log10 units) by plating 
on Mueller–Hinton Agar. Data at each time point corresponds to mean ± standard deviation. NS indicate no significant differences and asterisks indicate significant 
differences (*: p < 0.05; **: p < 0.01; ***: p < 0.001) between treated cells vs. the control (non-treated cells). p-values, indicate significant differences (p < 0.05) between the two 
honey concentrations tested. 
 
 
 
  
Figure 1. Effect of MkH on S. aureus CECT 86 (a) and E. coli CECT 515 (b) cell viability assessed
by colony forming units (CFU) counting (expressed in Log10 units) by plating on Mueller–Hinton
Agar. Data at each time point corresponds to mean ± standard deviation. NS indicate no significant
differences and asterisks indicate significant differences (*: p < 0.05; **: p < 0.01; ***: p < 0.001) between
treated cells vs. the control (non-treated cells). p-values, indicate significant differences (p < 0.05)
between the two honey concentrations tested.
2.1.2. Effects of MkH on Cytoplasmic Membrane Potential
Figure 2 represents the effects of MkH on the cytoplasmic membrane potential of S. aureus CECT
86 (a) and E. coli CECT 515 (b), in comparison to non-treated cells.
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p < 0.05) up to 180 min (SI = 1.61; p < 0.01) of treatment. Significant differences were observed between 
both treatments at 60 min (p < 0.01), 120 min (p < 0.05) and 180 min (p < 0.001). 
Regarding E. coli, cells treated with 20% (w/v) of MkH displayed a significant increase of 
fluorescence after 120 min of incubation (SI = 2.50; p < 0.001) (Figure 2b). The application of 30% (w/v) 
of MkH resulted in a time-dependent increase in the amount of depolarized cells between 60 min (SI 
= 2.85; p < 0.001) and 120 min (SI = 3.56; p < 0.001) of exposition (Figure 2b). Interestingly, after 120 
min, cells seemed to repolarize progressively under both treatment conditions. Significant differences 
Figure 2. Effect of MkH over membrane potential of S. aureus CECT 86 (a) and E. coli CECT 515 (b),
evaluated using DiBAC4 (3) staining. Data at each time point corresponds to mean± standard deviation.
NS indicate no significant differences and asterisks indicate significant differe ce (*: p< 0.05; **: p< 0.01;
***: p < 0.001) between treated c lls vs. the control (non-treated cells). p-values, i dicate significant
differences (p < 0.05) betwe n the two honey concentrations tested.
S. aureus treated with 10% (w/v) of MkH displayed a significant increase of fluorescence after
120 min of incubation (p < .05). Interestingly, after this time, cell memb ane seemed to repolarize,
re-establishing their membrane pot ntial (SI = 1.08; p = 0.068) (Figure 2a). Conversely, treatment with
20% (w/v) of MkH resulted in a time-dependent increase of depolarized cells from 60 min (SI = 1.24;
p < 0.05) up to 180 min (SI = 1.61; p < 0.01) of treatment. Significant differences were observed between
both treatments at 60 min (p < 0.01), 120 min (p < 0.05) and 180 min (p < 0.001).
Regarding E. coli, cells treated with 20% (w/v) of MkH displayed a significant increase of
fluorescence after 120 min of incubation (SI = 2.50; p < 0.001) (Figure 2b). The application of 30%
(w/v) of MkH resulted in a time-dependent increase in the amount of depolarized cells between
60 min (SI = 2.85; p < 0.001) and 120 min (SI = 3.56; p < 0.001) of exposition (Figure 2b). Interestingly,
after 120 min, cells seemed to repolarize progressively under both treatment conditions. Significant
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differences were observed between the two treatments at 60 min (p < 0.001), 120 min (p < 0.001) and
180 min (p < 0.001).
E. coli cells exhibited higher membrane depolarization than S. aureus cells exposed to the same
concentration of MkH (20% (w/v)). However, E. coli cells seemed to be able to restore MP progressively
after 120 min of treatment, regardless of the honey concentration.
These findings support the relevance of honey concentration and time of exposition upon the
increase of cell membrane depolarization in both bacteria.
2.1.3. Effects of MkH on Membrane Integrity
Figure 3 represents the effects of MkH on the membrane integrity of S. aureus CECT 86 (a) and
E. coli CECT 515 (b) compared with non-treated cells.
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Figure 3. Effect of MkH over membrane integrity of S. aureus CECT 86 (a) and E. coli CECT 515 (b),
evaluated using propidium iodide staining. Data at each time point corresponds to mean ± standard
deviation. NS indicate no significant differences and asterisks indicate significant differences (*: p < 0.05;
**: p < 0.01; ***: p < 0.001) between treated cells vs. the control (non-treated cells). p-values, indicate
significant differences (p < 0.05) between the two honey concentrations tested.
After MkH exposure, minor—yet significant—modificatio s in S. aureus membrane were observed
(Figure 3a), but not as an initial event. Indeed, significant differences in the SI were observed in cells
treated with 10% f MkH after 120 min of treatment (SI = 1.79; p < 0.01) increasing up to 180 in
(SI = 2.31; p < 0.001). On the other hand, cells t ed with 20% f MkH showed PI-intake after 60 min
(SI = 2.00; p < 0.001), increasing progressively following 120 and 180 min of treatment (SI = 2.38;
p < 0.001 and SI= 2.61; p < 0.001, respectively). Significant differences were also registered between
both experimental conditions at 60 min (p < 0.05), 120 min (p < 0.001) and 180 min (p < 0.01).
Differently, E. coli treated with 20% of MkH showed no significant differences when compared
with viable non-treated cells. Conversely, the treatment of E. coli cells with 30% (w/v) of MkH resulted
in a time-dependent increase of SI from the early stages of the treatment at 30 min (SI = 1.96; p < 0.01)
up to the end at 180 min (SI = 7.54; p < 0.001). Significant differences were observed between the two
treatments conditions at all time points.
2.1.4. Effects of MkH on Metabolic Activity
Figure 4 depicts the metabolic effects of MkH on S. aureus CECT 86 cells, presented as MIF (mean
intensity of fluorescence values).
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MIF displayed by viable non-treated cells increased slightly up for 180 min but without significant
differences along the time. Soon after 30 min of treatment with 10% (w/v) of MkH MIF decreased to
a value of 15.87 (p< 0.001) and decreased progressively up to the end of treatment (MIF = 7.33; p< 0.001).
The drastic reduction observed on MIF values could be explained by an extremely reduced metabolic
activity or by the loss of membrane integrity, which may lead to the loss of fluorescence. Cells treated
with 10% (w/v) of MkH showed significant PI-intake after 120 min f treatment. How ver, metabolic
activity decreased after 30 min of exposure at a similar co c ntration of honey. Thus, the second
hypothesis may be discarded, at least during the first stages of the treatment.
Although slight differences were registered between both treatment conditions, they were not
statistically significant (Figure 4). In addition, no significant differences were observed between
MkH-treated cells and death control (data not shown), that is cells after 120 min of treatment at 10%
(w/v) of MkH (MIF = 8.56; p = 0.324) and 60 min of treatment at 20% (w/v) (MIF = 15.08; p = 0.055).
This data suggests that m tabolic inactivation is less dependent from MkH concentration a d treatment
time than membrane depolarization and membrane lesion.
2.2. Manuka Honey Effect on Eﬄux Pumps in E. coli AG100TET
The results obtained regarding eﬄux pumps blockade of E. coli AG100TET are presented in
Figure 5. Viable non-treated bacteria were able to expulse EtBr so that the MIF was lower (MIF = 8.95)
compared to honey treated bacteria and to positive control (bacteria treated with chlorpromazine
(CPZ)). MIF of cells exposed to honey increased significantly at all concentrations tested 20% (w/v)
(MIF = 17.32; p < 0.01), 30% (w/v) (MIF = 18.92; p < 0.001), 40% (w/v) (MIF = 19.28; p < 0.001) and
50% (w/v) (MIF = 23.73; p < 0.001). In addition, no significant differences were observed between
MkH-treated cells at 50% (w/v) and positive control cells (MIF = 24.72; p = 0.475), suggesting that MkH
pr motes eﬄux pumps blockade in a dose-de end nt fashion.
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3. Discussion
The emergence of multi-drug-resistant bacteria poses a great worldwide problem for the agriculture
and food industries and rises public health concerns [1,2]. This situation makes necessary to search
for new effective alternatives. Antibacterial activity of MkH has been described in numerous studies,
which demonstrate that this type of honey could be promising as adjuvant therapy [8]. However, more
studies to elucidate how honey acts against bacteria are necessary [11,21–23].
The present study provides new i sights r garding the physiological effects of MkH upon S. aure s
and E. coli through FC. The ability of bacteria to deal with environmental stresses determines their
success to survive. Following the exposure to MkH, several physiological changes were registered,
both in S. aureus and E. coli. The effects of MkH on cell viability, cytoplasmic membrane potential
and membrane integrity were evaluated on S. aureus CECT 86 and E. coli CECT 515. Effects of MkH
on metabolic activity were assessed on S. aureus CECT 86. Finally, the effect of MkH on eﬄux pump
activity was valued in E. coli AG100TET strain.
A significant reduction of bacterial growth was observed after MkH exposure. This data suggest
that S. aureus and E. coli cells were not able to recover from the MkH induced alterations and lost their
viability as result of physiological changes. This effect seems to be irreversible up to the maximum
time tested, corroborating data published in other studies [9,12].
An essential aspect of bacterial adaptation to environmental conditions is the equilibrium of ion
concentration inside and outside of bacteria, hich determines c ll membrane potential (MP) [22].
In this study, bacterial MP alteration was confirmed by DiBAC4 (3) staining, although it was not
a relatively early event in both bacteria (Figure 2). However, under some treatment conditions, reversible
effects and repolarization of cell membrane were observed, which evidence that other underlying
mechanisms that caused bacterial death happened. Indeed, previous studies, using transcriptomics
and proteomics, described alterations in the expression level of some stress response genes [23,24].
Nevertheless, the physiological changes on MP of S. aureus and E. coli w re not previ usly described.
On the other hand, the loss of membrane integrity represents a meaningful damage for bacteria.
The results obtained in this study reveal that the treatment time and specially the MkH concentration are
key factors regarding the induction of membrane injury in both bacteria. Moreover, these results evinced
that the effect of MkH on membrane integrity seems to be slightly different between Gram-positive
and Gram-negative bacteria. Previous studies have also detected such differences among both types of
bacteria, while limited or no evidenc of cell lysis of S. aureus after MkH treatment was found [12,25].
In contrast, for Pseudomonas aeruginosa (another Gram-negative bacteria), there was evidence that
large amounts of extracellular material result of cellular lysis [26,27]. In addition, a reduction in
oprF gene expression in P. aeruginosa population treated with MkH was related to deficiencies on
membrane integrity [27]. For E. coli, such deficiencies might be related to ompA gene, orthologue to
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oprF with significant amino acid similarity [28]. Nevertheless, genomic studies are necessary to confirm
this assumption.
The influence of MkH on S. aureus metabolism was studied using calcein-AM. This compound is
a cell-permeant esterase substrate that measure enzymatic activity [20]. Esterases encompass a large
and sundry group of enzymes able to catalyse the cleavage and formation of carboxyl ester bonds.
Taking into account the results obtained, MkH induced a significant metabolism disruption on S. aureus
cells as an early event. Previous studies, comprising genomics and/or proteomics, demonstrated that
MkH induces a reduction in the expression of genes and proteins involved in energy metabolism of
S. aureus [9,10]. However, it has been described that changes in gene expression does not necessarily
concur with a bacterial physiological response to stress or with the altered levels of protein expression
determined by proteomic analysis [9]. The considerable repercussion upon metabolic bacterial
physiology observed in this study might be related to the previously described genomic alterations.
The effect of MkH on metabolic activity of E. coli cells was not assessed because Gram-negative bacteria
are not permeable to calcein-AM [29]. Nevertheless, the results obtained using S. aureus encourage the
search of other alternatives to evaluate metabolic disruption. Moreover, studies on E. coli [23], as well
as on P. aeruginosa [30] confirmed the effect of MkH on the ability of bacteria to scavenge iron, which
is essential for bacterial metabolism and survival. The assessment of MkH influence on metabolic
activity of E. coli using FC, could confirm metabolic status alterations, which might be related with the
results observed in other studies.
The effect of MkH on eﬄux pump activity was also assessed on E. coli AG100TET, a bacterial
strain which over-expresses several eﬄux pumps when exposed to high concentrations of tetracycline.
Eﬄux pumps can be specific to antibiotics, although most of them are multidrug transporters that are
capable to pump a wide range of unrelated compounds and thus, significantly contribute to multidrug
resistance [31,32]. Some studies have demonstrated the synergism or additive antibacterial effects
between MkH and some antibiotics such as tetracycline, rifampicin, imipinem or mupirocin [13,33–35].
In spite of that, the underlying mechanisms were not suggested. These findings strongly suggest that
MkH is able to block eﬄux activity. Conversely, a previous study addressing the global action of MkH
on E. coli demonstrated that following exposure, some genes belonging to the EvgAS regulon—used by
E. coli in adaptive responses to acid, osmotic and drug resistance—were upregulated [23]. This disparity
could indicate no correlation between gene expression and bacterial physiological response or might be
related with a possible metabolic disruption, since antibiotic eﬄux is an energy-dependent mechanism.
To validate this last hypothesis, it would be necessary to confirm this specific MkH effect on E. coli.
This study demonstrated that MkH induced effects on the physiology of bacteria, as result of their
effort to adapt and overcome from a stressful environment. MkH effects did not occur as an initial event,
with the exception of metabolic disruption, and were dependent on honey concentration. However,
the final result observed was the reduction of cell viability. Due to its complex composition, with
multiple active components, MkH acts in a multifactorial way upon several cellular target sites, as was
confirmed in this study, which hinders the development of bacterial specific defence mechanisms and,
therefore, resistance [13,36].
4. Conclusions
The global escalation in antibiotic resistance means that alternative antimicrobials are essential.
Our results demonstrate that MkH induced a remarkable metabolic disruption as primary physiological
effect on S. aureus. Other effects, such as the membrane potential imbalance and the membrane injury
were also detected in both reference strains. The eﬄux pump blockade observed in E. coli AG100TET
was dependent on honey concentration. This finding could encourage further studies to know the
effect of MkH-antibiotic combinations over bacterial physiological effect, addressing especially those
which are usually extruded from bacteria by eﬄux mechanisms.
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Data presented in this study are in accordance with previous findings on antibacterial action
mechanisms of MkH, carried out using other methodologies. This fact corroborate that FC is a valuable
tool for analysing physiological states of bacteria exposed to honey.
Further studies using other varieties of honey with demonstrated antibacterial activity are
necessary to elucidate whether the action mechanisms described for MkH are similar in other types
of honey.
5. Materials and Methods
5.1. Bacterial Strains, Growth Conditions and Inoculated Broth Preparation
Staphylococcus aureus (CECT 86) and Escherichia coli (CECT 515) from the Spanish Type Culture
Collection were used as Gram-positive and Gram-negative bacteria models, respectively. Reference
strains were used instead of clinical or resistant isolates in order to avoid a possible altered response
mechanism to MkH exposure, which could confound the effects of honey upon bacteria. In addition,
E. coli AG100TET (kindly provided by Dr. Miguel Viveiros), an AG100 progeny strain, which
over-expresses several eﬄux pumps when exposed to high concentrations of tetracycline [37], was
used for studying MkH effect on eﬄux pumps. Prior to experiments, bacteria were subcultured twice
in MH agar to ensure the purity of cultures.
In order to analyse the kinetics of bacterial growth and to determine, the bacteria exponential
phase, a study of the growth curves was carried out. For this purpose, 100 mL of Mueller Hinton (MH;
Sigma-Aldrich, St. Louis, Mo., USA) broth were inoculated in an Erlenmeyer flask with an overnight
culture of bacteria to obtain an optical density OD600 absorbance of 0.100, approximately corresponding
to 1 × 108 CFU/mL. This culture was prepared by transferring an isolated colony (from a fresh culture
in Mueller Hinton (MH) agar) into MH broth; overnight culture was then incubated for 16 h in 50 mL
of MH broth. The flask was placed in a shaker incubator at 37 ◦C and 180 rpm. Aliquots were taken
every half hour to read the absorbance at 600 nm until growth curves reached stationary phase. At the
described conditions, the exponential growth phase of S. aureus occurred between 2 h and 8.5 h,
and between 1 h and 8 h for E. coli strains (Figure 6a).
All flow cytometric assays were performed using a cell suspension prepared with MH broth and
bacteria in initial exponential growth phase. Briefly, following the same conditions used for the study
of growth curves, sterile MH broth was inoculated with an overnight culture of bacteria until reaching
OD600 absorbance of 0.100. Once the exponential phase was reached after incubation at 37 ◦C and
180 rpm during 2.5 h for S. aureus and 1.5 h for E. coli strains, a bacteria cell suspension corresponding
to 108 bacteria cells/mL was prepared for the flow cytometric assays (Figure 6b).
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5.2. Bacterial Susceptibility to Manuka Honey
Manuka honey MGO 550+ (containing at least 550 mg of methylglyoxal per kg of honey) (Manuka
Health, New Zealand) was used in this study. Minimal inhibitory concentration (MIC) and minimal
lethal concentration (MLC) were previously determined according to the Clinical and Laboratory
Standards Institute M07-A9 protocol [38]. MIC and MLC were defined as 10% (w/v) for S. aureus and
20 % (w/v) for E. coli strains [39].
A stock solution of 0.8 g/mL of the MkH sample (the maximum concentration of honey able to
solubilize) in MH sterile broth was prepared in sterile Falcon tubes to carry out the following assays.
Complete dissolution of honey was achieved with intense agitation.
5.3. Evaluation of Cell Viability
The evaluation of cell viability was performed for S. aureus CECT 86 and E. coli CECT 515.
The concentrations of MkH tested were selected according to the susceptibility results: 10% and 20%
(w/v) for S. aureus and 20% and 30% (w/v) for E. coli [39]. The final volume was 1 mL in all assays.
In sterile Eppendorf tubes, variable volumes (between 0.625 and 0.875 mL) of the inoculums (108
bacteria cells/mL in exponential growth phase) and variable volumes (between 0.125 and 0.375 mL) of
the stock solution of MkH to achieve the target concentrations were mixed and incubated for 30, 60,
120 and 180 min at 37 ◦C and 180 rpm (Figure 6c).
After each treatment, bacterial suspensions were centrifuged at 13,000× g (Eppendorf Centrifuge
5804R, Hamburg, Germany) for 5 min. The supernatant was discarded and the pellets were washed
twice with 1 mL of phosphate saline buffer (PBS; Sigma-Aldrich, St. Louis, Mo., USA) in order to
prevent antibacterial carryover. Afterwards, bacteria were resuspended with 1 mL of PBS. Cell viability
was determined by counting colony forming units per mL (CFU/mL) (Figure 6c). Briefly, the number
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of viable cells for each treatment was determined by plating 100 µL of serial dilutions on MH agar
plates. The number of CFU/mL was determined and compared with that of the control plates (not
exposed to honey) after incubation at 37 ◦C for 24 h.
5.4. Functional Characterization of Manuka Honey-Induced Action
The physiological status of bacterial cells following exposure to different concentrations of MkH
in a time course assay were assessed by FC. Previous FC assays [14,21,40,41] were adapted to honey
peculiarities. For protocol optimisation, several important factors were taken into account, among
which the microorganisms involved, the fluorochromes and its concentration, honey concentrations
and incubation times [18].
Following the same protocol used in the evaluation of cell viability, the appropriate volumes of the
inoculated MH broth and a MkH dilution in sterile broth to achieve the target concentrations of MkH
((10% and 20% (w/v) for S. aureus CECT 86, 20% and 30% (w/v) for E. coli CECT 515) were incubated in
sterile Eppendorf tubes at 37◦C and 180 rpm for different times (30, 60, 120 and 180 min). In all assays,
the final volume was 1 mL. For each strain, non-treated cells were used as negative control and cells
treated with 1 mL of ethanol 70% (w/w) as positive control (Figure 6c).
After each treatment, the pellets were obtained and washed twice with 1 mL of PBS and then
resuspended and stained with 1 mL of PBS containing the different fluorochromes at the concentrations
detailed below. In addition, non-treated and non-stained cells were also analysed in order to evaluate
the native cell autofluorescence.
All cytometric assays were performed using a standard FACS Calibur TM (BD Biosciences,
Franklin Lakes, NH, USA) equipped with 3 photomultipliers, standard filters, and a 15 mW, 488 nm
argon laser, using Cell Quest Pro software version4.0.2 (BD Biosciences, Franklin Lakes, NJ, USA).
Data was recorded for 20,000 cells for each assay.
Due to honey characteristics and the sensitivity of some fluorochromes to acidity, the pH evaluation
was performed for each assay.
5.4.1. Assessment of Membrane Potential
The effect of MkH on cell membrane potential of the reference strains was evaluated using
bis-(1,3-dibutylbarbituric acid) trimethineoxonol (DiBAC4 (3); Sigma-Aldrich, Munich, Germany) as
described by Teixeira-Santos et al. (2015). After honey treatment, cells were incubated for 15 min in the
dark at 37 ◦C and 180 rpm with 0.5 mg/L of DiBAC4 (3). DiBAC4 (3) enters only depolarized cells, where
it binds reversibly to membrane and intracellular components, resulting in an increased fluorescent
signal [20]. The fluorescence intensity (FI) was registered at FL1 (absorbance at 530 nm). A staining
index (SI) was defined as the ratio between the FI of treated cells and the FI of non-treated cells.
5.4.2. Assessment of Membrane Integrity
Cell membrane integrity of the two reference strains was assessed with propidium iodide (PI;
Sigma-Aldrich, Munich, Germany) staining. After honey treatment, bacteria were stained with 1 mg/L
of PI for 30 min at 37 ◦C and 180 rpm in darkness. PI is a cell viability marker which enters cells only
when membrane has been seriously injured and exhibits fluorescence after binding to nucleic acids [20].
FI was measured at FL3 (Absorbance at 630 nm). A SI was also defined, as the ratio between the FI of
treated cells and the FI of non-treated cells.
5.4.3. Assessment of Metabolic Activity
Metabolic changes induced by MkH on S. aureus CECT86 were evaluated using the fluorogenic
substrate calcein-AM (Sigma-Aldrich, Munich, Germany) at a concentration of 1 mg/L for 120 min at
37 ◦C and 180 rpm in darkness. Only metabolically active cells are able to hydrolyse calcein-AM to
a fluorescent compound by intracellular esterases. This compound accumulates inside cells with intact
membranes and increases their fluorescence. When cells have an injured membrane, impermeant
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end products will be quickly lost to the extracellular space, resulting to a decreased fluorescent
signal [20]. FI was registered at FL1. Mean intensity of fluorescence (MIF) was used to evaluate
treatment differences.
5.4.4. Assessment of Eﬄux Pumps
The effect of MkH on eﬄux pumps was evaluated in E. coli AG100TET strain, following the protocol
described by Paixão et al. (2009) involving accumulation and eﬄux assays using 1 mg/L of ethidium
bromide (EtBr; Sigma-Aldrich, Munich, Germany). Bacteria treated with 20 mg/L of chlorpromazine
(CPZ; Sigma-Aldrich Química SA Madrid, Spain), an eﬄux pump inhibitor, was used as positive
control. EtBr is a common eﬄux pump substrate; under normal conditions EtBr enters the bacteria and
is rejected to outside by eﬄux pump action. In case these pumps are blocked EtBr accumulates inside
the bacteria, increasing its fluorescence [37].
In this assay four concentrations of MkH (20%, 30%, 40% and 50%) were tested. Bacterial
suspensions were incubated for 60 min at 37 ◦C and 180 rpm in darkness. The fluorescence intensity
(FI) was measured at FL3. MIF was used to evaluate treatment differences.
5.5. Statistical Analysis
All experimental procedures were replicated three times using fresh culture preparations; the
results were expressed in all cases as mean values and respective standard deviations
The statistical analysis was performed using IBM SPSS statistics v.24.0 (SPSS, Chicago, IL, USA).
All variables were tested for the assumptions of normality and homoscedasticity. Paired-sample
Student’s t-test or Wilcoxon signed rank test (parametric or nor parametric test depending on the
characteristics of the variables) were used to evaluate if there were any differences between non-treated
bacteria and MkH treated bacteria at the different time points sampled in each assay. In addition,
unpaired-sample Student’s t-test or Mann-Whitney test (parametric or nor parametric test depending
on the characteristics of the variables) were used to compare the differences between the two MkH
concentrations tested in each assay. p < 0.05 was considered to be significant.
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